1Biro K,Noszek L,Prekopp P,et al.Characteristics and Risk Factors of Cisplatin-Induced Ototoxity in Testicular Cancer Patients Detected by Distorsion Product Otoacoustic Emission[J].Oncology,2006,70(3):177-184. 被引量：1
2Teranish M,Nakashima T,Wakabayashi T.Effect of alpha tocopherol on cisplatin induced ototoxicity in guinea pigs[J].Hear Res,2001,151(1-2):61-70. 被引量：1
3Low WK,Yoh ST,Wee J,et al.Sensorineural hearing loss after radiotherapy and chemoradiotherapy:a single,blinded,randomized study[J].J Clin Oncol,2006,20;24(12):1904-1909. 被引量：1
5Bradford D,Kasi S,Thomas J,et al.Effect of cisplatin chemotherapy on otoacoustic emission:the development of an objective screening protocol[J].Otolaryngol Head Neck Surg,1999,121:693-701. 被引量：1
6Toral-Martinon R,Shkurovich-Bialik P,Collado-Corona MA,et al.Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment[J].Arch Med Res,2003,34(3):205-8. 被引量：1
7Sininger YS,Cone-Wesson B.Threshold prediction using ABR and SSEPs with infant and young children.JackKatz Handbook of Clinical Audiology[M].5th Edition,2002,307-321. 被引量：1
8Perez-Abalo MC.Steady state responses to multiple amplitude modulated tones:an optimized method to test frequencyspecific thresholds in hearing-impaired children and normalhearing subjects[J].Ear Hear,2001,22:200-211. 被引量：1
1[3]Sininger YS, Cone-Wesson B. Threshold prediction using ABR and SSEPs with infant and young children. In: Jack Katz. Handbook of clinical audiology. 5th Edition. Baltimore: Williams & Wilkins, 2002; 307-321. 被引量：1
2[4]Kuwada S, Anderson JB, Batra R, et al. Sources of the scalp-recorded amplitude-modulation following response. J Am Acad Audiol. 2002; 13: 188-204. 被引量：1
3[5]Picton TW, Dimitrijevic A, John ms. Multiple auditory steady-state responses.Ann Otol Rhinol Laryngol Suppl. 2002; 189: 16-21. 被引量：1
4[6]Perez-Abalo MC. Steady state responses to multiple amplitudemodulated tones:an optimized method to test frequency-specific thresholds in hearing-impaired children and normal-hearing subjects. Ear Hear. 2001; 22:200-211. 被引量：1
5Simon T, Hero B, Dupuis W, et al. The incidence of hearing impairment after successful treatment of neuroblastoma.Klin Padiatr, 2002, 214 : 149 - 152. 被引量：1
6Oh SH, Yu WS, Song BH, et al. Expression of heat shock protein 72 in rat cochlea with cisplatin-induced acute ototoxicity. Acta Otolaryngol, 2000, 120 : 146 - 150. 被引量：1
8Church MW, Kaltenbach JA, Blaidey BW, et al. The comparative effects of sodium thiosulfate,-diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res, 1995, 86 : 195 - 203. 被引量：1
9Tandy JR, Tandy RD, Farris P, et al. In vivo interaction of cis-platinum and fosfomycin on squamous cell carcinoma.Laryngoscope, 2000, 110 : 1222 - 1224. 被引量：1
10Sha S, Taylor R, Forge A, et al. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res, 2001, 155 : 1 -8. 被引量：1
6Park HR, Ju EJ, Jo SK, et al. Enhanced antitumor efficacy of cispla- tin in combination with HemoHIM in tumor-bearing mice [J]. BMC cancer, 2009, 9(1) : 85-95. 被引量：1
7Bosch ME, Sanchez AJ, Rojas FS, et al. Analytical methodologies for the determination of cisplatin [ J ]. J Pharmaceut Biomed Anal, 2008, 47(3) : 451-459. 被引量：1
8Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecu- lax level (Review) [J]. Oncol Rep, 2003, 10(6) : 1663-1682. 被引量：1
10All BH, A1 Moundhri MS. Agents ameliorating or augmenting the nephrotoxieity of eisplatin and other platinum compounds : a review of some recent research[J]. Food Chem Toxicol, 2006, 44(8) : 1173- 1183. 被引量：1
